Dr. Mary-Elizabeth Patti is a physician-scientist, serving as a Principal Investigator at Joslin Diabetes Center, Director of the Hypoglycemia Clinic, Co-Director of the Molecular Phenotyping Core, and Associate Professor of Medicine at Harvard Medical School.
Dr. Patti’s NIH-funded lab focuses on identification of molecular/epigenetic mechanisms by which nutritional exposures during early life increase diabetes risk in subsequent generations. Translational studies are focused on mechanisms contributing to diabetes resolution and hypoglycemia after bariatric surgery.
She has published extensively on this issue, most recently A Randomized, Placebo-Controlled Double-Blind Trial of a Closed-Loop Glucagon System fo Post-Bariatric Hypoglycemia
RSS